BCRX vs TSM Stock Comparison

TSM currently leads BCRX in this stock comparison, with AIQ scores of 67 vs 59. The clearest difference is momentum, while BCRX has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 8 points
BCRX
Healthcare
vs
TSM
Technology
BCRX
BioCryst Pharmaceuticals, Inc.
Price
$7.61
Day move
-0.91%
AIQ Score
59/100
Best edge
Value
Sector
Healthcare
TSM
Taiwan Semiconductor Manufacturing Company Limited
Leads
Price
$399
Day move
-1.67%
AIQ Score
67/100
Best edge
Momentum
Sector
Technology

What is the main difference between BCRX and TSM?

TSM leads the current stock comparison as Taiwan Semiconductor Manufacturing Company Limited, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

BioCryst Pharmaceuticals, Inc. vs Taiwan Semiconductor Manufacturing Company Limited

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Technology· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

TSM leads

TSM leads by 8 AIQ points, primarily on Momentum and Quality, but the lead has narrowed from 12 points over 30 sessions.

Fragile: 3 of 6 evidence groups support TSM, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Weakening
BCRX

BioCryst Pharmaceuticals, Inc.

AIQ Score
59/100
AIQ Edge Score
6/10
TSM

Taiwan Semiconductor Manufacturing Company Limited

Leads
AIQ Score
67/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors TSM over BCRX, 67 versus 59 as of Nov 15, 2026. TSM's advantage is driven primarily by stronger momentum and quality, while BCRX holds the stronger value profile. TSM also shows the stronger technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor TSM today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. TSM lead: Weakening — the AIQ differential moved from 12 to 8 points over 30 sessions.

Compare BioCryst Pharmaceuticals, Inc. and Taiwan Semiconductor Manufacturing Company Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BCRX
-36.6%
TSM
+257.5%

Total return comparison

Growth of $10,000, distributions reinvested

BCRX $6,336 · TSM $35,753

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BCRX and TSM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BCRX advantage
0
TSM advantage
  • Momentum42 vs 66
    TSM +24
  • Value86 vs 66
    BCRX +20
  • Quality64 vs 74
    TSM +10
  • Risk Resilience55 vs 58
    Even

3 of 6 evidence groups favor TSM. TSM’s edge is concentrated in momentum and quality; BCRX keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BCRX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

TSM0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Price Lost 200-Day MA — bearish, trend, long horizon

TSM's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — BCRX and TSM both carry a full feed there.

The central trade-off

TSM (Taiwan Semiconductor Manufacturing Company Limited): the stronger current systematic profile, led by momentum and quality.

BCRX (BioCryst Pharmaceuticals, Inc.): the counter-case, on value, valuation.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

TSM

TSM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

TSM

TSM on combined revenue and EPS growth.

Value

BCRX

BCRX on the peer-relative Value factor, by 20 points.

Momentum

TSM

TSM on the Momentum factor, by 24 points.

Lower downside

BCRX

BCRX carries the lower 1-month annualized volatility.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBCRXTSMNote
Implied upside to target+44.5%+44.5%Level
Target dispersion0%+26.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1122Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor TSM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreTSM59 vs 67
FundamentalsTSMrevenue growth -17.4% vs 17.6%; EPS growth -51.6% vs 8%; TTM ROE -9.5% vs 10.9%; gross margin 25.3% vs 65.8%; operating margin -30.1% vs 57.9%
ValuationBCRXValue 86 vs 66
TechnicalsTSMPrice vs 50-day -7.6% vs -7.3%; vs 200-day -13.5% vs -1.1%
Risk ResilienceEvenRisk Resilience 55 vs 58
Analyst expectationsEvenTarget upside 44.5% vs 44.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BCRX and TSM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 8 points.
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TSM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

TSM lead: Weakening — the AIQ differential moved from 12 to 8 points over 30 sessions.

May 27BCRX leads above the line · TSM leads belowNov 13
Today
TSM +8
59 vs 67
7 sessions ago
TSM +6
62 vs 68
30 sessions ago
TSM +12
60 vs 72
90 sessions ago
BCRX +3
71 vs 68

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BCRX

0 bullish / 2 bearish / 2 neutral

Only BCRX

  • Death Cross Active — bearish, trend, long horizon (6.91%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
TSMConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only TSM

  • Golden Cross Active — bullish, trend, long horizon (6.71%)
  • Price Lost 200-Day MA — bearish, trend, long horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

TSM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BCRXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.91%, AIQ 0 points).

TSMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.67%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BCRX closes the Momentum gap — currently 24 points behind, the largest single contributor to TSM's edge.
  2. 2BCRX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3TSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 8-point move would eliminate TSM's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

TSM leads on balance
MetricBCRXTSM
Revenue growth (YoY)-17.4%17.6%
EPS growth (YoY)-51.6%8%
Gross margin25.3%65.8%
Operating margin-30.1%57.9%
Return on equity (TTM)-9.5%10.9%
Debt to equity-2.080.14

Performance

TSM leads 5 of 6 windows
MetricBCRXTSM
1 week (5 sessions)-1%6.2%
1 month (20 sessions)-2.3%-3.4%
3 months (63 sessions)-23.4%-7.5%
6 months (126 sessions)-15.6%-1.4%
Year to date-2.4%31.2%
1 year (252 sessions)6%37.2%

Technicals

TSM has the stronger structure
MetricBCRXTSM
RSI (14)40.745.3
ADX (14)15.229.2
Price vs 50-day-7.6%-7.3%
Price vs 200-day-13.5%-1.1%
Volatility (1M, annualized)45.2%61.7%

Risk

Split
MetricBCRXTSM
Beta0.652.16
Sharpe ratio0.360.95
Sortino ratio0.561.37
Max drawdown-32.2%-27.3%
Current drawdown-31.5%-17.9%
Annualized volatility48.1%41.8%
Value at risk (95%)-4.1%-4.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BCRX or TSM?

On the Algovestiq AIQ Score, TSM is the stronger of the two as of Nov 15, 2026, scoring 67 against BCRX's 59. The edge comes from momentum and quality. BCRX is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BCRX or TSM the better buy right now?

TSM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor TSM over BCRX?

The composite weights Quality, Value, Momentum and Risk Resilience. TSM leads Momentum by 24 points; BCRX leads Value by 20 points; TSM leads Quality by 10 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BCRX or TSM?

Analyst price targets imply +44.5% upside for BCRX and +44.5% for TSM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BCRX or TSM?

BCRX is the better-valued of the two on the peer-relative Value factor. BCRX on the peer-relative Value factor, by 20 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BCRX or TSM?

TSM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BCRX or TSM?

TSM on the Momentum factor, by 24 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BCRX or TSM?

BCRX is the more resilient of the two, so the other name carries the higher downside risk. BCRX carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BCRX more profitable than TSM?

TSM leads on the comparable margin measures — gross margin 25.3% vs 65.8%; operating margin -30.1% vs 57.9%; ttm roe -9.5% vs 10.9%.

Is TSM's lead over BCRX getting stronger or weaker?

TSM lead: Weakening — the AIQ differential moved from 12 to 8 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the BCRX vs TSM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BCRX closes the Momentum gap — currently 24 points behind, the largest single contributor to TSM's edge; BCRX's Death Cross Active resolves — a bearish trend rule currently active against it; TSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 8-point move would eliminate TSM's advantage entirely.

What do the current signals say about BCRX and TSM?

BCRX: 0 bullish / 2 bearish / 2 neutral. TSM: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BCRX is Death Cross Active (bearish, long horizon). On TSM it is Golden Cross Active (bullish, long horizon).

Compare BCRX and TSM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.